Literature DB >> 15817303

Nucleocytoplasmic shuttling of clock proteins.

Filippo Tamanini1, Kazuhiro Yagita, Hitoshi Okamura, Gijsbertus T J van der Horst.   

Abstract

The mammalian circadian clock in the neurons of suprachiasmatic nuclei (SCN) in the brain and in cells of peripheral tissues is driven by a self-sustained molecular oscillator, which generates rhythmic gene expression with a periodicity of about 24?h (Reppert and Weaver, 2002). This molecular oscillator is composed of interacting positive and negative transcription/translation feedback loops in which the heterodimeric transcription activator CLOCK?BMAL1 promotes the transcription of E-box containing Cryptochrome (Cry1 and Cry2) and Period (Per1 and Per2) genes, as well as clock-controlled output genes. After being synthesized in the cytoplasm, CRY and PER proteins feedback in the nucleus to inhibit the transactivation mediated by positive regulators. The mPER2 protein acts at the interphase between positive and negative feedback loops by indirectly promoting the circadian transcription of the Bmal1 gene (through RevErbalpha) (Preitner et al., 2002; Shearman et al., 2000) and by interacting with mCRY proteins (Kume et al., 1999; Yagita et al., 2002) (for a detailed review, see Reppert and Weaver, 2002). In addition to cyclic transcription of clock genes, immunohistochemical studies on SCN neurons have revealed that mCRY1, mCRY2, mPER1, and mPER2 proteins undergo near synchronous circadian patterns of nuclear abundance (Field et al., 2000). The delay of approximately 6h between the peak in clock mRNA production and maximal levels of protein expression in the nucleus is believed to originate from posttranslational modification steps involving phosphorylation, ubiquitination, and proteosomal degradation. Thus, the timing of entry, as well as the residence time of core clock proteins into the nucleus, is a critical step in maintaining the correct pace of the circadian clock. Several clock proteins have been shown to contain nuclear export signal, sequences, on top of nuclear import signals, that facilitate their cellular trafficking (Chopin-Delannoy et al., 2003; Miyazaki et al., 2001; Yagita et al., 2002). This type of dynamic intracellular movement not only regulates protein localization, but also often affects functions by determining interactive partners and protein turnover. Because most of the clock genes have been identified by genetic screening in Drosophila and by gene knockdown in mammals, the development of innovative cellular techniques is essential in learning the structure-function and regulation of the corresponding proteins. This article discusses approaches, limitations, and applicable protocols to study the regulation of cellular localization of mammalian clock proteins, with a particular focus on mammalian CRY1 and PER2 proteins.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15817303     DOI: 10.1016/S0076-6879(05)93020-6

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  21 in total

1.  Of switches and hourglasses: regulation of subcellular traffic in circadian clocks by phosphorylation.

Authors:  Ozgür Tataroğlu; Tobias Schafmeier
Journal:  EMBO Rep       Date:  2010-11-05       Impact factor: 8.807

2.  Cryptochromes impair phosphorylation of transcriptional activators in the clock: a general mechanism for circadian repression.

Authors:  Hugues Dardente; Erin E Fortier; Vincent Martineau; Nicolas Cermakian
Journal:  Biochem J       Date:  2007-03-15       Impact factor: 3.857

3.  Nucleolar localization and circadian regulation of Per2S, a novel splicing variant of the Period 2 gene.

Authors:  Daniele Avitabile; Licia Genovese; Donatella Ponti; Danilo Ranieri; Salvatore Raffa; Antonella Calogero; Maria Rosaria Torrisi
Journal:  Cell Mol Life Sci       Date:  2013-11-08       Impact factor: 9.261

4.  Phosphorylation modulates rapid nucleocytoplasmic shuttling and cytoplasmic accumulation of Neurospora clock protein FRQ on a circadian time scale.

Authors:  Axel C R Diernfellner; Christina Querfurth; Carlos Salazar; Thomas Höfer; Michael Brunner
Journal:  Genes Dev       Date:  2009-09-15       Impact factor: 11.361

5.  In Vivo Imaging of the Central and Peripheral Effects of Sleep Deprivation and Suprachiasmatic Nuclei Lesion on PERIOD-2 Protein in Mice.

Authors:  Thomas Curie; Stephanie Maret; Yann Emmenegger; Paul Franken
Journal:  Sleep       Date:  2015-09-01       Impact factor: 5.849

6.  Modeling of a human circadian mutation yields insights into clock regulation by PER2.

Authors:  Y Xu; K L Toh; C R Jones; J-Y Shin; Y-H Fu; L J Ptácek
Journal:  Cell       Date:  2007-01-12       Impact factor: 41.582

7.  Model-driven experimental approach reveals the complex regulatory distribution of p53 by the circadian factor Period 2.

Authors:  Tetsuya Gotoh; Jae Kyoung Kim; Jingjing Liu; Marian Vila-Caballer; Philip E Stauffer; John J Tyson; Carla V Finkielstein
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-09       Impact factor: 11.205

8.  Cerebellar Purkinje cells incorporate immunoglobulins and immunotoxins in vitro: implications for human neurological disease and immunotherapeutics.

Authors:  Kenneth E Hill; Susan A Clawson; John W Rose; Noel G Carlson; John E Greenlee
Journal:  J Neuroinflammation       Date:  2009-10-29       Impact factor: 8.322

9.  Functional motifs in the (6-4) photolyase crystal structure make a comparative framework for DNA repair photolyases and clock cryptochromes.

Authors:  Kenichi Hitomi; Luciano DiTacchio; Andrew S Arvai; Junpei Yamamoto; Sang-Tae Kim; Takeshi Todo; John A Tainer; Shigenori Iwai; Satchidananda Panda; Elizabeth D Getzoff
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-09       Impact factor: 11.205

10.  Targeted degradation of PSEUDO-RESPONSE REGULATOR5 by an SCFZTL complex regulates clock function and photomorphogenesis in Arabidopsis thaliana.

Authors:  Takatoshi Kiba; Rossana Henriques; Hitoshi Sakakibara; Nam-Hai Chua
Journal:  Plant Cell       Date:  2007-08-10       Impact factor: 11.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.